| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.16 | 0.4 |